Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
EPA, Bayer Worked Closely Together To Reinstate Dicamba: Report September 7, 2021 Irvin Jackson Add Your CommentsA new investigative report suggests there may have been inappropriate collaboration between Bayer and federal environmental regulators, as part of an effort to get the weedkiller dicamba back on the market, following a ban required by a federal court and report of wide-spread crop damage over the past few years.Dicamba is a synthetic herbicide sold under various brand names, including Xtend, Xtendiimax, Engenia and Fexapen, which have been used for years by farmers nationwide to control weeds.While dicamba was originally only applied during certain times of the year, use of the herbicide increased dramatically after new genetically modified seeds were introduced in 2016, which were intended to make crops tolerant of the weed killer. This was designed to allow farmers to use dicamba โover-the-topโ, as the crops were emerging from the ground. However, this has resulted in unintended crop damage as the dicamba drifted onto neighboring farms, which did not use the genetically modified seeds.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONIn June 2020, the U.S. Ninth Circuit Court of Appeals vacated the U.S. Environmental Protection Agency (EPA) prior approval of dicamba formulations, after determining the agency did not pay enough attention to the risk of dicamba crop damage on neighboring farms.Many thought the weed killer was dead at that point, but, according to a St. Louis Post-Dispatch investigative report, Bayer began preparing an outline for the EPA on how to return dicamba to the market almost immediately. By July 3, less than a month after the courtโs decision, Bayer had submitted an application to get dicamba approved for sale yet again by the EPA.The investigative report indicates more than 50 EPA employees then began essentially working for Bayer to reregister the pesticide, and the companies communicated back and forth repeatedly over multiple versions of the label, essentially collaborating on them until the FDA announced approval of a new dicamba formula in late October 2020, which Bayer claimed would no longer drift to other fields.However, documents from during that time show the EPA seeking “concurrence” with Bayer over changes it was making to the label, essentially asking their permission. The EPA also reportedly allowed Bayer to reject certain changes to the label that the agencyโs experts thought were necessary.In contrast, the report notes that other stakeholders, such as farmers and environmental groups, do not get that kind of access to the EPA or the approval process. Nor are they given the opportunity to veto aspects of product labels like corporations appear to be given.EPA was asking permission and approval from Bayer, BASF and Syngenta for tweaks it made to the label up to the last couple hours before final approval, as seen in the flurry of communications between the agency and dicamba registrants just hours before approval, which were obtained by the Post-Dispatch.Dicamba LawsuitsDozens ofย dicamba drift lawsuitsย have been filed since August 2017, alleging that Monsanto rushed a system to market that encouraged the increased use of dicamba, while withholding or concealing information from regulatory authorities about the volatility of dicamba-resistant crops.Farmers and environmental groups say the herbicide drifts onto neighboring crops that are not dicamba tolerant, killing them and forcing farmers to buy the genetically engineered seeds so their crops arenโt killed by dicamba.In February 2020, a Missouri jury awarded $265 millionย to a peach farmer in the first dicamba crop damage lawsuit to go to trial. The verdict included $15 million in compensatory damages and $250 million in punitive damages, designed to punish Monsanto and BASF for their reckless behavior in marketing the widespread use of the weed killer.The dicamba lawsuits claimed the high volatility is seen as a feature by the manufacturers, meant to force other farmers to use their expensive products to grow dicamba-tolerant GMO crops if they donโt want to suffer losses when their neighbors spray. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: BASF, Bayer, Dicamba, Engenia, Genetically Modified Organisms, Herbicide, Soybeans, Weed Killer, XtendMore Roundup Lawsuit Stories MDL Judge Urged To Block $7.25B Roundup Non-Hodgkinโs Lymphoma Settlement April 28, 2026 Judge Grants Preliminary Approval to Roundup Lawsuit Settlement Plan March 5, 2026 $7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits February 18, 2026 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (Posted: today)The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.MORE ABOUT: BARD POWERPORT LAWSUITJury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (04/16/2026)Judge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026) Dupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (Posted: yesterday)A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโs lymphoma.MORE ABOUT: DUPIXENT LAWSUITLink Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month (04/21/2026) Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization (Posted: 2 days ago)Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.MORE ABOUT: OMNIPOD RECALL LAWSUITRecalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (04/30/2026)Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)
$7.25B Roundup Class Settlement Proposed To Resolve Non-Hodgkin’s Lymphoma Lawsuits February 18, 2026
Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (Posted: today)The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.MORE ABOUT: BARD POWERPORT LAWSUITJury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (04/16/2026)Judge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026)
Dupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (Posted: yesterday)A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโs lymphoma.MORE ABOUT: DUPIXENT LAWSUITLink Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month (04/21/2026)
Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization (Posted: 2 days ago)Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.MORE ABOUT: OMNIPOD RECALL LAWSUITRecalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (04/30/2026)Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)